REINVENT Trademark

Trademark Overview

On Wednesday, September 2, 2020, a trademark application was filed for REINVENT with the United States Patent and Trademark Office. The USPTO has given the REINVENT trademark a serial number of 90154354. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 17, 2023. This trademark is owned by Integra LifeSciences Corporation. The REINVENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of soft tissue regeneration; medical and scientific research in the field of nerve or tendon repair; scientific research for medical purposes in the field of soft tissue regeneration; scientific research for medical purposes in the field of nerve or tendon repair; clinical research in the field of soft tissue regeneration; clinical research in the field of nerve or tendon repair; medical and scientific research, namely, conducting clinical trials for others; compiling data for clinical research purposes in the field of nerve or tendon repair; medical and scientific research, data collection and analysis in the nature of clinical research in the fields of nerve or tendon repair
reinvent

General Information

Serial Number90154354
Word MarkREINVENT
Filing DateWednesday, September 2, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesMedical and scientific research in the field of soft tissue regeneration; medical and scientific research in the field of nerve or tendon repair; scientific research for medical purposes in the field of soft tissue regeneration; scientific research for medical purposes in the field of nerve or tendon repair; clinical research in the field of soft tissue regeneration; clinical research in the field of nerve or tendon repair; medical and scientific research, namely, conducting clinical trials for others; compiling data for clinical research purposes in the field of nerve or tendon repair; medical and scientific research, data collection and analysis in the nature of clinical research in the fields of nerve or tendon repair

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 7, 2020
Primary Code042
First Use Anywhere DateFriday, July 22, 2022
First Use In Commerce DateFriday, July 22, 2022

Trademark Owner History

Party NameIntegra LifeSciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameIntegra LifeSciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Wednesday, May 17, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 17, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, May 17, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, November 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 2, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 2, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, November 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 1, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, October 21, 2022USE AMENDMENT FILED
Tuesday, November 1, 2022SOU EXTENSION 3 GRANTED
Friday, October 21, 2022SOU EXTENSION 3 FILED
Tuesday, November 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 21, 2022TEAS EXTENSION RECEIVED
Friday, October 21, 2022TEAS STATEMENT OF USE RECEIVED
Friday, April 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 13, 2022SOU EXTENSION 2 GRANTED
Wednesday, April 13, 2022SOU EXTENSION 2 FILED
Wednesday, April 13, 2022TEAS EXTENSION RECEIVED
Tuesday, October 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 22, 2021SOU EXTENSION 1 GRANTED
Friday, October 22, 2021SOU EXTENSION 1 FILED
Friday, October 22, 2021TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 22, 2021EXAMINER'S AMENDMENT ENTERED
Friday, January 22, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 22, 2021EXAMINERS AMENDMENT E-MAILED
Friday, January 22, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, January 7, 2021ASSIGNED TO EXAMINER
Wednesday, October 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 5, 2020NEW APPLICATION ENTERED

Related Keywords

reinvent research field medical scientific nerve repair clinical tendon purposes regeneration